Trial intelligence / Profile preview

Chloroprocaine vs Bupivacaine for Cervical Cerclage

NCT02862912Phase 4Completed

Sponsor
Columbia University
Start
Nov 2016
Primary completion
Jan 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of chloroprocaine in Cervical insufficiency (CI) (2 arms), sponsored by Columbia University. Primary endpoint: Time to Resolution of Motor Block at 3 hours. Started Nov 2016; status: completed.

02

Drugs

chloroprocaine
03

Conditions

Cervical insufficiency (CI)

Beyond the preview

Go deeper on NCT02862912.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02862912.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call